Obesity Is Not a Factor in Racial or Ethnic Disparities in Cancer Screening Adherence

Share this content:

Adherence to cancer screening recommendations was not found to vary by race/ethnicity and body weight/obesity. In a focused look at the influence of body mass index (BMI) as a measure of obesity, researchers found some screening disparities may be decreasing. These findings were reported in Journal of Women's Health (doi:10.1089/jwh.2015.5270).

Although the higher rate of cancer-related deaths among racial minorities has often been attributed to disparities in adherence to cancer screening recommendations, this study found no notable variation in likelihood to follow cancer screening recommendations for Pap test and mammography among racial/ethnic groups in a national sample of women classified by BMI as underweight, normal weight, overweight, or obese.

Among Black women, those who were overweight were less likely to undergo a Pap test than those who were underweight or normal weight. Other disparities in cancer screening adherence were associated with age, insurance coverage, and income among racial/ethnic groups in this study's sample population.

The study was conducted by Jacqueline Hirth, PhD, MPH; Tabassum Haque Laz, MBBS, PhD; Mahbubur Rahman, MBBS, PhD, MPH; and Abbey Berenson, MD, PhD, all from University of Texas Medical Branch, Galveston.

The authors concluded that although the Affordable Care Act is expected to reduce the number of uninsured persons in the United States, more screening opportunities are needed for uninsured or low-income women, who may not know how to access care.

This research was supported by the National Center for Advancing Translational Sciences and the National Institute of Allergy and Infectious Diseases.

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs